Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer.
Liu C, Fan D, Sun J, Li G, Du R, Zuo X, Zhang K, Zhang W, Wang S, Li X, Du M, Wang D, Hao Q, Zhang Y, Li M, Zhang C, Gao Y.
Liu C, et al. Among authors: gao y.
J Nanobiotechnology. 2025 Jan 3;23(1):3. doi: 10.1186/s12951-024-03021-2.
J Nanobiotechnology. 2025.
PMID: 39754249